Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests. Researchers will evaluate whether these blood tests will help people ages 45 to 75 find cancer early when it may be easier to treat.

This is the first study of the Cancer Screening Research Network (CSRN), a nationwide network that will run trials aimed at improving cancer screening that is funded by the National Cancer Institute (NCI).

Read the Fred Hutch press release.

NCI is accepting applications for the NCI Cancer Prevention Fellowship Program (CPFP). The CPFP empowers postdoctoral fellows to become leading scientists in domestic and global prevention research through comprehensive career training, collaborative research opportunities, and professional partnerships. If you know a researcher with interests in the field of cancer prevention and related areas, share this opportunity with them.

Applications for the 2026 cohort will be accepted through September 12, 2025.

Learn more about the program.

Apply to be a CPFP fellow.

The NCI Division of Cancer Prevention Early Career Scientist Opportunity highlights early career scientists who are advancing research within the areas supported by DCP, including:

• Cancer Early Detection Biomarker Development and Screening
• Intervention Development for Cancer Prevention
• Precision Cancer Prevention
• Symptom Science and Management

Selected nominees are invited to present their research in the Early Career Scientist Spotlight Seminar Series and will have the opportunity to meet with staff involved in cancer prevention research across DCP and NCI.

The deadline for nominations is Thursday, July 31.

Learn more about this opportunity.

Wednesday, July 30
3:00 – 4:00 p.m. ET
Advance registration required

This webinar will review the current state of research on evaluating and managing treatment-related cardiotoxicities. Drs. Herrmann and Ruddy will discuss the state of the science in cardio-oncology, management of cardiotoxicities, and exciting new tools and directions for cardio-oncology research.

Speakers

Joerg Herrmann, M.D.
Cardiologist Director, Cardio-Oncology Clinic Director for Research, Ischemic Heart Disease Program
Mayo Clinic Comprehensive Cancer Center

Kathryn J. Ruddy, M.D., M.P.H., FASCO
Oncologist Co-leader, Cancer Prevention Control & Survivorship Research Program
Mayo Clinic Comprehensive Cancer Center                        

Moderators

Eileen Dimond, R.N., M.S.
NCI Division of Cancer Prevention

Bishow Adhikari, Ph.D.
NHLBI Division of Cardiovascular Sciences

Learn more about the DCP Building Bridges Symptom Science Webinar Series.